About Xinwen

About Xinwen

Innovative transdermal drug delivery technology as the core biopharmaceutical product technology platform

Company Profile

Innovative transdermal drug delivery technology as the core biopharmaceutical product technology platform

Jiaxing Photovoltaic Technology Park (Research Center)

1000 square meters

Preparation study/analytical study/transdermal test/stability study

Jiashan Guigu Technology Park

2000 square meters

GMP production workshop Xinwen Biopharmaceutical Technology (Jiashan) Co., Ltd

1.pngProfessional technical team

2.pngProfessional instruments and equipment

Corporate Vision

1.jpg

Building a first-class high-quality medical laboratory in the industry

4.jpg

Focusing on high-end medical service projects with cutting-edge precision

3.jpg

Carry out clinical characteristic testing projects

3.jpg

Provide personalized and customized medical testing services

Development history

Xinwen Biopharmaceutical Technology (Jiashan) Co., Ltd
Established on March 31, 2021

2023.2

Xinwen Biopharmaceutical Technology (Jiashan) Co., Ltd. was awarded the title of "Talent Strong Enterprise" in Luoxing Street, Jiashan County

2022.6

Xinwen Biopharmaceutical's first major health product - adopting HETDS ® Successful development and production of melatonin patch based on technology

2021.12

Xinwen Biomedical Technology (Jiashan) Co., Ltd. has completed the decoration of the laboratory, GMP workshop, and office workshop, and the equipment and facilities have started trial operation

2021.4

Founder Zhang Xin was recommended by the Luoxing Sub district Office of the People's Government of Jiashan County and selected for the "Innovation Jiashan. Elite Leadership Plan" quick review project

2021.4

Jiaxing Xinwen Biotechnology Co., Ltd. has signed a "Technical Entrustment Development Contract" with Changzhou Siyao Pharmaceutical Co., Ltd., entrusted with the pilot development, process, and registration application guidance of transdermal patch products

2021.3

Jiaxing Xinwen Biotechnology Co., Ltd. has signed a project investment agreement with the Jiashan County Guigu Park Management Committee to establish a wholly-owned subsidiary in Jiashan - Xinwen Biomedical Technology (Jiashan) Co., Ltd

2021.3

Jiaxing Xinwen Biotechnology Co., Ltd. Completed the First Round of Financing

2019.6

The first domestic transdermal sufentanil patch developed for Yichang Humanwell obtained clinical approval from the State Drug Administration

2018.6

The Huzhou Transdermal Drug Delivery Research Laboratory has been relocated to Jiaxing, and the Jiaxing Innovative Formulation Biopharmaceutical Product Experimental Center has officially opened

2017.10

Awarded the title of "Zhejiang Province Science and Technology oriented Small and Medium Enterprises"

2015.10

Signed a "Technical Entrustment Development Contract" with Yichang Humanwell Pharmaceutical Co., Ltd., entrusted with the pilot development, process, and registration application guidance of transdermal patch products


2015.5

Rent laboratory space in Huzhou South the Taihu Lake Science and Technology Innovation Center to establish transdermal drug delivery research laboratory


2015.1

The founder of the company, Zhang Xinjian, has carried out a project on the development of a new transdermal drug delivery technology platform and products, which has been recognized by the Jiaxing Municipal Government as Class A of the "Innovative Jiaxing Elite Leading Plan".


Management team